MedTrace Logo

Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery

NCT05687253 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-08-01

No results posted yet for this study

Summary

Assessment of Intubation conditions following administration of neuromuscular blocking agents; BX1000 (investigational) or rocuronium (active control).

Conditions

  • Neuromuscular Blockade
  • Anesthesia
  • Surgery

Interventions

DRUG

BX1000

IV BX1000

DRUG

Rocuronium Bromide

IV Rocuronium

Sponsors & Collaborators

  • Baudax Bio

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2023-04-10
Completion
2023-05-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05687253 on ClinicalTrials.gov